Therapeutic transplant can bump survival rate from near zero to 70-80 percentNewswise (press release)Experts within the center work together to create individual treatment plans that range from noninvasive medical and interventional therapies to comple…
|
US/EU Idiopathic pulmonary fibrosis drug sales “to rise 86.6%/year to 2017”
PharmaTimes … damage to the lung resulting from inflammation and scarring – has been overlooked by the healthcare industry until the last decade and, with no fully-effective therapies other than lung transplantation, very little is understood about its … |
|
Trinity’s Opsona begins phase II trial for renal transplant drug
Businessandleadership.com OPN-305 is a novel proprietary humanized IgG4 monoclonal antibody (MAb) against toll-like receptor 2 (TLR2), a target within the innate immune system, and is under development as a treatment for the prevention of DGF following renal transplantation. |
UAB surgeon named to new position promoting diversity, combating health …The Birmingham News – al.comYoung, who joined UAB in 1997, is director of the pancreas transplant program and director of pediatric renal transplantation. His research focuses o…
|
Helping Kids With Severe Respiratory Failure Survive Until Lung Transplantation
RedOrbit Adults with end-stage respiratory failure and pulmonary hypertension requiring ECMO (extracorporeal membrane oxygenation) have been “bridged” toward lung transplantation with novel lung assist devices such as the Novalung. This and related devices … |
|
ECMO can be used on neonates with severe respiratory failure until lung …
News-Medical.net Adults with end-stage respiratory failure and pulmonary hypertension requiring ECMO (extracorporeal membrane oxygenation) have been “bridged” toward lung transplantation with novel lung assist devices such as the Novalung. This and related devices … |
UPENN AlmanacNational Jewish Sports Hall of Fame: Mr. BilskyUPENN AlmanacDr. Joel D. Cooper,a professor of surgery at the Perelman School of Medicine at the University of Pennsylvania who has made innovative contributions to lung transplantation, will …
|
New Antiviral Treatment Could Significantly Reduce Global Burden of Hepatitis C
Science Daily (press release) May 6, 2013 — Around 150 million people globally are chronically infected with the hepatitis C virus (HCV) — a major cause of liver disease and the fastest growing cause of liver transplantation and liver cancer.1 New prevention strategies are … New Hepatitis C Treatment Offers 90% Cure, May Halve Infection Rate In …Medical Daily |
Annals of Internal Medicine tip sheet for May 7, 2013 – PhysOrg.comPhys.OrgThis is an important consideration when weighing the net benefit of lung transplantation. Past studies have focused on patient LAS at transplantation, but evidence shows that pa…
|
Helping kids with severe respiratory failure survive until lung transplantation
Science Codex Minneapolis, MN, May 6, 2013 – Adults with end-stage respiratory failure and pulmonary hypertension requiring ECMO (extracorporeal membrane oxygenation) have been “bridged” toward lung transplantation with novel lung assist devices such as the … |